Color doppler ultrasound follow-up of infantile hemangiomas and peripheral vascularity in patients treated with propranolol

Pediatric Dermatology

Volumn 32, Issue 4, 2015, Pages 468-475

  Kutz, Ana M ^a   Aranibar, Ligia ^a   Lobos, Nelson ^a   Wortsman, Ximena ^b  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

PROPRANOLOL;

ABSENCE OF SIDE EFFECTS; ARTICLE; BLOOD VESSEL WALL; CAPILLARY HEMANGIOMA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COLOR ULTRASOUND FLOWMETRY; FEMALE; FOLLOW UP; HUMAN; INFANT; MALE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME ULTRASOUND SCANNER; SYSTEMIC THERAPY; TREATMENT RESPONSE; TUMOR VOLUME; ECHOGRAPHY; HEMANGIOMA; NEWBORN; PRESCHOOL CHILD; SKIN NEOPLASMS; TREATMENT OUTCOME; VASCULARIZATION;

CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROPRANOLOL; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84937164701     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12596     Document Type: Article

References (30)

1. Almaraz RL, Gutiérrez JC, Bieler CB, et al., Infantile vascular tumors. An Pediatr (Barc) 2010; 72: 143.e1-143.e15.
2. Restrepo R, Palani R, Cervantes LF, et al., Hemangiomas revisited: the useful, the unusual and the new. Part 1: overview and clinical and imaging characteristics. Pediatr Radiol 2011; 41: 895-904.
3. Haggstrom AN, Drolet BA, Baselga E, et al., Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007; 150: 291-294.
4. Dickison P, Christou E, Wargon O,. A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol 2011; 28: 663-669.
5. Hochman M, Adams DM, Reeves TD,. Current knowledge and management of vascular anomalies I Hemangiomas. Arch Facial Plast Surg 2011; 13: 145-151.
6. Boye E, Olsen BR,. Signaling mechanisms in infantile hemangioma. Curr Opin Hematol 2009; 16: 202-208.
7. Schwartz RA, Sidor MI, Musumeci ML, et al., Infantile haemangiomas: a challenge in paediatric dermatology. J Eur Acad Dermatol Venereol 2010; 24: 631-638.
8. Holland KE, Drolet BA,. Infantile hemangioma. Pediatr Clin North Am 2010; 57: 1069-1083.
9. Bruckner AL, Frieden IJ,. Infantile hemangiomas. J Am Acad Dermatol 2006; 55: 671-682.
10. Bruckner AL, Frieden IJ,. Hemangiomas of infancy. J Am Acad Dermatol 2003; 48: 477-493.
11. Rossler L, Rothoeft T, Teig N, et al., Ultrasound and color Doppler in infantile subglottic haemangioma. Pediatr Radiol 2011; 41: 1421-1428.
12. Wortsman X, Wortsman J,. Clinical usefulness of variable-frequency ultrasound in localized lesions of the skin. J Am Acad Dermatol 2010; 62: 247-256.
13. Resalkar DD, Chu WC, Cheng FW, et al., An institutional review of pediatric haemangiomas: prevalence, imaging features, and outcomes. Hong Kong Med J 2010; 16: 334-340.
14. Paltiel HJ, Burrows PE, Kozakewich HP, et al., Soft tissue vascular anomalies: utility of US for diagnosis. Radiology 2000; 214: 747-754.
15. Wortsman X,. Common applications of dermatologic sonography. J Ultrasound Med 2012; 31: 97-111.
16. Dubois J, Patriquin HB, Garel L, et al., Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography. AJR Am J Roentgenol 1998; 171: 247-252.
17. Dubois J, Alison M,. Vascular anomalies: what a radiologist needs to know. Pediatr Radiol 2010; 40: 895-905.
18. Navarro OM,. Imaging of benign pediatric soft tissue tumors. Semin Musculoskelet Radiol 2009; 13: 196-209.
19. Wester ST, Johnson TE,. Echographic evidence of regression of a periocular infantile capillary hemangioma treated with systemic propranolol. Ophthalmic Surg Lasers Imaging 2011; 42: 18-21.
20. Navarro OM,. Soft tissue masses in children. Radiol Clin North Am 2011; 49: 1235-1259.
21. Sans V, de la Roque ED, Berge J, et al., Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124: 423-431.
22. Storch CH, Hoeger PH,. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163: 269-274.
23. Sanchéz-Carpintero I, Ruiz-Rodriguez R, Lõpez-Gutiérrez JC,. Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks and recommendations. Actas Dermosifiliogr 2011; 102: 766-779.
24. Hogeling M, Adams S, Wargon O,. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics 2011; 128: 259-266.
25. Drolet BA, Frommelt PC, Chamlin SL, et al., Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 2013; 131: 128-140.
26. Schupp CJ, Kleber JB, Gunther P, et al., Propranolol therapy in 55 infants with hemangioma: dosage, duration, adverse effects and outcome. Pediatr Dermatol 2011; 28: 640-644.
27. Bingham MM, Saltzman B, Vo NJ, et al., Propranolol reduces infantile hemangioma volume and vessel density. Otolaryngol Head Neck Surg 2012; 147: 338-344.
28. Talaat AA, Elbasiouny MS, Elgendy DS, et al., Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations. J Pediatr Surg 2012; 47: 707-714.
29. Chang LC, Haggstrom AN, Drolet BA, et al., Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008; 122: 360-367.
30. Bauland CG, Lüning TH, Smit JM, et al., Untreated hemangiomas: growth pattern and residual lesions. Plast Reconstr Surg 2011; 127: 1643-1648.